Drug profile · INN
naproxcinod
BEPRANA
naproxcinod (BEPRANA) is a cyclooxygenase inhibitor.
EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — naproxcinod
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
naproxcinod (BEPRANA) is a cyclooxygenase inhibitor.
Key facts
INN naproxcinod
Brand BEPRANA
Mechanism Cyclooxygenase inhibitor
Target Cyclooxygenase
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is naproxcinod?
naproxcinod (BEPRANA) is a cyclooxygenase inhibitor.
What is the brand name for naproxcinod?
BEPRANA is a marketed brand name for naproxcinod. Check FDA Drugs@FDA for the current US label holder and prescribing information.